Impact of Histologic Concordance Between Biopsies and the Endoscopic Resection Specimen, in the Treatment of Barrett's Esophagus in Dysplasia, on the Recurrence of Dysplasia

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03685799

Acronym

PatheBarett

Enrollment

Registered

2018-09-26

Start date

2016-05-31

Completion date

2016-06-30

Last updated

2018-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Barretts Esophagus With Dysplasia

Keywords

Barretts Esophagus, Dysplasia

Brief summary

Influence of histological concordance on the risk of recurrence: the histological concordance being the comparison between the biopsies and the endoscopic resection piece and its concordant response rate.

Detailed description

Interventions

DIAGNOSTIC_TESTPathological revision

Pathological revision

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* patients with DHG on Barrett's esophagus on endoscopic biopsies followed by endoscopic resection.

Exclusion criteria

Design outcomes

Primary

Measure	Time frame	Description
Influence of histological concordance on the risk of recurrence	1 day	the histological concordance being the comparison between the biopsies and the endoscopic resection piece and its concordant response rate.

Secondary

Measure	Time frame	Description
Identification of histological factors of recurrence.	1 day	Identification of histological factors of recurrence.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026